Published Engineering Inflammatory Disease Treatment Microbial exopolysaccharides for prevention and treatment of inflammatory disease By University of Massachusetts, Amherst
Published Medical PAR2 Antagonists Orally active small molecule antagonists of the human protease-activated receptor 2 developed for potential treatment of inflammatory diseases, metabolic syndrome & cancer By The University of Queensland
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
